Moolec Science (MLECW) Convertible Debt (2023 - 2026)
Moolec Science (MLECW) posted Convertible Debt of $21.0 million for Q1 2026, up 57.16% sequentially from $13.4 million in Q4 2025.
Moolec Science (MLECW) Convertible Debt (2023 - 2026) Analysis & Trends
Moolec Science has reported Convertible Debt for 4 years, with the latest figure at $21.0 million in Q1 2026.
- Quarterly Convertible Debt changed N/A year-over-year to $21.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.0 million (changed N/A YoY) and the FY2025 annual result came in at $18.3 million, down 77.4% from the prior year.
- Convertible Debt improved to $21.0 million in Q1 2026 per MLECW's latest filing, from $13.4 million in the prior quarter.
- Over five years, Convertible Debt peaked at $80.8 million in Q2 2024 and troughed at $13.4 million in Q4 2025.
- A 4-year average of $41.7 million and a median of $21.0 million in 2026 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2024 and 2025: Convertible Debt rose 7.44% in 2024, then slumped 77.4% in 2025.
- Over 4 years, Convertible Debt stood at $75.2 million in 2023, then climbed by 7.44% to $80.8 million in 2024, then sank by 83.46% to $13.4 million in 2025, then surged by 57.16% to $21.0 million in 2026.
- According to Business Quant data, Convertible Debt over the past three periods registered $21.0 million, $13.4 million, and $18.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.00 Mn |
| Dec 31, 2025 | 13.36 Mn |
| Jun 30, 2025 | 18.26 Mn |
| Jun 30, 2024 | 80.81 Mn |
| Jun 30, 2023 | 75.21 Mn |